ES2073391T3 - Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre. - Google Patents

Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.

Info

Publication number
ES2073391T3
ES2073391T3 ES87309685T ES87309685T ES2073391T3 ES 2073391 T3 ES2073391 T3 ES 2073391T3 ES 87309685 T ES87309685 T ES 87309685T ES 87309685 T ES87309685 T ES 87309685T ES 2073391 T3 ES2073391 T3 ES 2073391T3
Authority
ES
Spain
Prior art keywords
treatment
therapeutic compositions
disorders
blood loss
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87309685T
Other languages
English (en)
Inventor
Donogh Paul O'brien
Gordon Allen Vehar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25453974&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2073391(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2073391T3 publication Critical patent/ES2073391T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EL USO DE FACTOR DE PROTEINA DE TEJIDOS O SUS ANTAGONISTAS EN COMPOSICIONES TERAPEUTICAS PARA EL TRATAMIENTO DE DESORDENES SANGUINEOS, POR EJEMPLO LOS CARACTERIZADOS POR UNA TENDENCIA HACIA LA HEMORRAGIA O UN ESTADO HIPERCOAGULATIVO.
ES87309685T 1986-11-04 1987-11-02 Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre. Expired - Lifetime ES2073391T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92697786A 1986-11-04 1986-11-04

Publications (1)

Publication Number Publication Date
ES2073391T3 true ES2073391T3 (es) 1995-08-16

Family

ID=25453974

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87309685T Expired - Lifetime ES2073391T3 (es) 1986-11-04 1987-11-02 Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.

Country Status (8)

Country Link
EP (1) EP0266993B1 (es)
JP (1) JP2758162B2 (es)
AT (1) ATE120645T1 (es)
CA (1) CA1317878C (es)
DE (1) DE3751218T2 (es)
ES (1) ES2073391T3 (es)
NZ (1) NZ222434A (es)
ZA (1) ZA878249B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589173A (en) * 1986-11-04 1996-12-31 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
WO1990008956A1 (en) * 1989-02-02 1990-08-09 Teijin Limited Detection of human tissue factor activator
US6749853B1 (en) 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
ATE244579T1 (de) 1997-01-22 2003-07-15 Univ Texas Verfahren und zusammensetzungen des gewebefaktors zur koagulation und behandlung von tumoren
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
AU750414B2 (en) 1998-07-13 2002-07-18 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
WO2000004148A1 (en) 1998-07-15 2000-01-27 Genentech, Inc. Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
US6703494B2 (en) 2000-03-16 2004-03-09 Genentech, Inc. Anti-tissue factor antibodies with enhanced anticoagulant potency
EP1749536A1 (en) * 2005-08-03 2007-02-07 Thrombotargets Europe, S.L. Activated factor X stimulants as new antihemorrhagic agents for topical use
US7772371B2 (en) 2005-08-03 2010-08-10 Thrombotargets Corporation Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents
WO2016150449A1 (en) * 2015-03-23 2016-09-29 Dana Genetic A/S Recombinant soluble human tissue factor, method of its production and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL64879C (es) * 1944-05-20
DE3150596A1 (de) * 1981-12-21 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von gewebsthromboplastin

Also Published As

Publication number Publication date
NZ222434A (en) 1990-06-26
ATE120645T1 (de) 1995-04-15
EP0266993A3 (en) 1988-07-27
JP2758162B2 (ja) 1998-05-28
CA1317878C (en) 1993-05-18
EP0266993A2 (en) 1988-05-11
DE3751218T2 (de) 1995-11-09
ZA878249B (en) 1989-07-26
JPS63218625A (ja) 1988-09-12
DE3751218D1 (de) 1995-05-11
EP0266993B1 (en) 1995-04-05

Similar Documents

Publication Publication Date Title
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
DE69010840D1 (de) Sterile chirurgische Nadel-Nähfaden-Zusammensetzung.
DE3854376D1 (de) Nähgerät für arthroskopische Chirurgie.
DE3850914D1 (de) Gerät für die thermische Therapie von Körpergeweben.
DE3689889D1 (de) Hochfrequenz-Chirurgiegerät für die thermische Koagulation biologischer Gewebe.
DE3587563D1 (de) Absorbierbares Gewebe für chirurgische Eingriffe.
DE3481164D1 (de) Einrichtung fuer die ophthalmologische chirurgie.
DE59009175D1 (de) Endoskop für die nasale Chirurgie.
IT8123070A0 (it) Preparato che favorisce la coagulazione del sangue a base di proteine umani, nonche'procedimento per la preparazione
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
ES278010Y (es) Clavo oseo, especialmente clavo de boqueo, para el tratamiento de fracturas de hueso
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
DE68915503D1 (de) Zahnchirurgisches Gerät, geeignet für die Versorgung von gekoppelten Handstücken mit drei unterschiedlichen Fluida.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
ZA878249B (en) Method and therapeutic compositions for the treatment of bleeding disorders
FI913818A0 (fi) Nytt trombolytiskt aemne.
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
DE69007486D1 (de) Verwendung von calciumantagonisten für die behandlung von narben.
FR2570266B1 (fr) Dispositif ecarteur, notamment pour la chirurgie du rachis
IT8147599A0 (it) Tavolo operatorio per la chirurgia dell'occhio
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 266993

Country of ref document: ES